FierceBiotech 26 mai 2026 Lilly inks deals to buy 3 vaccine developers for up to $3.8B as M&A spree continues
FierceBiotech 26 mai 2026 Facing looming Xtandi patent cliff, Astellas pins hopes on more deals while still cutting costs
Eli Lilly 26 mai 2026 Lilly inks deals to buy 3 vaccine developers for up to $3.8B as M&A spree continues - Fierce Biotech
Eli Lilly 26 mai 2026 Lilly announces three acquisitions to build infectious disease portfolio | Eli Lilly and Company - investor.lilly.com
10x Genomics News 26 mai 2026 Targeted single-cell RNA and perturbation sequencing with TAP-seq - Nature
BioPharma Dive 26 mai 2026 SR One’s Simeon George on how China is rewriting biotech’s venture playbook
Endpoints News 26 mai 2026 Lilly reports new data on PCSK9 base editing gene therapy from Verve buyout
GCC 26 mai 2026 Regeneron Pharmaceuticals to set up Global Capability Centre (GCC) in Hyderabad - Telangana Today